Studies on Vigora 100 mg, which contains Sildenafil Citrate as its active ingredient, are generally part of the broader body of research on Sildenafil and its effectiveness in treating erectile dysfunction (ED). While specific studies focused solely on Vigora 100 mg might not be extensively published, there is substantial research on Sildenafil Citrate, the compound used in Vigora, which provides insight into its efficacy and safety.

Key sources of published studies on Sildenafil Citrate (and by extension, products like Vigora 100 mg) include:

Medical Journals: Studies on Sildenafil Citrate are often published in peer-reviewed medical journals such as:

The New England Journal of Medicine

The Journal of Urology

The British Journal of Clinical Pharmacology

Urology

Clinical Trials: Clinical trials and their results, often available through databases such as ClinicalTrials.gov, provide information on the efficacy and safety of Sildenafil, including various formulations and brands.

Pharmaceutical Companies: Research published by pharmaceutical companies that manufacture Sildenafil, like Pfizer, which originally developed Viagra, provides data on its use. Although Vigora 100 mg is a generic version, these studies are still relevant as they often explore the active ingredient’s effects and safety.

Review Articles: Systematic reviews and meta-analyses that compile data from multiple studies provide comprehensive insights into the effectiveness and safety of Sildenafil across different formulations and dosages.

For specific studies on Vigora 100 mg, searching medical databases such as PubMed or Google Scholar with terms related to Vigora and Sildenafil might yield relevant research articles. If you need detailed and specific research papers, consulting a medical library or a healthcare provider for access to these resources may be helpful.